Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid type A (GABA_A) receptor is a pentameric ligand-gated chloride channel that mediates the majority of fast inhibitory neurotransmission in the central nervous system (Sigel & Steinmann, 2012). This specific target grouping focuses on receptors containing alpha-3, alpha-5, or alpha-6 subunits, which exhibit distinct anatomical distributions and physiological roles compared to the more prevalent alpha-1 subtype (Rudolph & Knoflach, 2011). Alpha-3 subunits are primarily found in the reticular nucleus of the thalamus and are linked to sensorimotor gating and muscle relaxation (Möhler, 2006). Alpha-5 subunits are predominantly extrasynaptic in the hippocampus and play a critical role in tonic inhibition and cognitive processes like learning and memory (Engin et al., 2018). Alpha-6 subunits are largely restricted to cerebellar granule cells and are involved in motor coordination and sensory processing (Sieghart, 1995). Pharmacological modulation of these specific subtypes is a key strategy for developing treatments for anxiety, cognitive deficits in schizophrenia, and certain types of epilepsy, while aiming to avoid the sedative side effects associated with alpha-1 activation (Rudolph & Knoflach, 2011).
Positive or negative allosteric modulation of the GABA-induced chloride current at the benzodiazepine binding site or distinct subunit interfaces.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-3, alpha-5, and alpha-6 subunit-containing subtypes (GABA_A receptor (alpha3/alpha5/alpha6)).